Microplastics found in lung cancer patients
Analysis based on 8 articles · First reported Sep 03, 2026 · Last updated Sep 22, 2026
The findings may increase public and regulatory attention on plastic pollution and its health impacts, potentially affecting industries reliant on plastics such as packaging and textiles. However, as an early-stage research finding, immediate market impact is limited, though it could influence future environmental regulations and healthcare research funding.
Research presented at the European Respiratory Society Congress in Barcelona, Spain, found that patients with lung cancer are more likely to have microplastics in their lungs and in larger quantities than those without cancer. The study, led by Dr Ilias Dimeas from University College Dublin and the University of Thessaly, analyzed lung samples from 100 patients at University Hospital of Larissa in Greece. Of these, 50 were diagnosed with lung cancer. Microplastics were detected in 70% of all patients, with lung cancer patients showing higher detection rates (66% vs 46%) and greater overall burden. Polypropylene and polyethylene were the most common types found. The study suggests microplastics may enter the body through inhalation and could be linked to lung disease, though causality is not established. Researchers are conducting further experiments to understand interactions with lung cells. Professor Barbara Hoffmann of the Heinrich Heine University Düsseldorf and the European Respiratory Society Advocacy Council commented on the findings, emphasizing the need for more research and advocating for clean air.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard